Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Unattractive Despite the Financial Engineering

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Dasin Retail Trust / Equity Capital Markets

<p>China Zhongshan City based Dasin Retail Trust plans to raise US$100m through its IPO in Singapore. In this insight, we will analyse the deal's fundamentals, its financials, valuation and its scores in our Smartkarma ECM Framework.</p><hr><div><h2>Deal and framework score overview</h2></div><p>Regular readers will be familiar with the below embed from our IPO tool which has been designed to provide you with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the…</p>

China Zhongshan City based Dasin Retail Trust plans to raise US$100m through its IPO in Singapore. In this insight, we will analyse the deal's fundamentals, its financials, valuation and its scores in our Smartkarma ECM Framework.Deal and framework score overviewRegular readers will be familiar with the below embed from our IPO tool which has been designed to provide you with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the…

Mapletree North Asia Commercial Trust (MAGIC SP)

Dasin Retail Trust IPO: Sponsor Waiver Will Increase DPU by 122%